171 related articles for article (PubMed ID: 32980699)
1. Laser-assisted rapid evaporative ionisation mass spectrometry (LA-REIMS) as a metabolomics platform in cervical cancer screening.
Paraskevaidi M; Cameron SJS; Whelan E; Bowden S; Tzafetas M; Mitra A; Semertzidou A; Athanasiou A; Bennett PR; MacIntyre DA; Takats Z; Kyrgiou M
EBioMedicine; 2020 Oct; 60():103017. PubMed ID: 32980699
[TBL] [Abstract][Full Text] [Related]
2. Off-Colony Screening of Biosynthetic Libraries by Rapid Laser-Enabled Mass Spectrometry.
Gowers GF; Cameron SJS; Perdones-Montero A; Bell D; Chee SM; Kern M; Tew D; Ellis T; Takáts Z
ACS Synth Biol; 2019 Nov; 8(11):2566-2575. PubMed ID: 31622554
[TBL] [Abstract][Full Text] [Related]
3. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
4. [Performance of vaginal self-sampling high-risk HPV genotyping as primary and combining cytology or viral load as secondary in cervical cancer screening].
Guo CL; Luo HX; Wang C; Qu XF; Yang B; Belinson JL; Du H; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2021 Apr; 56(4):271-279. PubMed ID: 33902239
[No Abstract] [Full Text] [Related]
5. Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study.
Chatzistamatiou K; Moysiadis T; Angelis E; Kaufmann A; Skenderi A; Jansen-Duerr P; Lekka I; Kilintzis V; Angelidou S; Katsiki E; Hagemann I; Tsertanidou A; Koch I; Boecher O; Soutschek E; Maglaveras N; Agorastos T
Arch Gynecol Obstet; 2017 May; 295(5):1247-1257. PubMed ID: 28337594
[TBL] [Abstract][Full Text] [Related]
6. Triage of high-risk HPV positive women in cervical cancer screening.
Ebisch RM; Siebers AG; Bosgraaf RP; Massuger LF; Bekkers RL; Melchers WJ
Expert Rev Anticancer Ther; 2016 Oct; 16(10):1073-85. PubMed ID: 27598683
[TBL] [Abstract][Full Text] [Related]
7. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Srisomboon J; Intaraphet S; Siriaunkgul S
PLoS One; 2016; 11(6):e0158184. PubMed ID: 27336913
[TBL] [Abstract][Full Text] [Related]
8. The ideal strategy for cervical cancer screening in Japan: Result from the Fukui Cervical Cancer Screening Study.
Kurokawa T; Onuma T; Shinagawa A; Chino Y; Kobayashi M; Yoshida Y
Cytopathology; 2018 Aug; 29(4):361-367. PubMed ID: 29768678
[TBL] [Abstract][Full Text] [Related]
9. Triage of women with negative cytology and positive high-risk HPV: an analysis of data from the SHENCCAST II/III studies.
Goodrich SK; Pretorius RG; Du H; Wu R; Belinson JL
J Low Genit Tract Dis; 2014 Apr; 18(2):122-7. PubMed ID: 24270196
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of novel, lower cost molecular human papillomavirus-based tests for cervical cancer screening in rural china.
Valdez M; Jeronimo J; Bansil P; Qiao YL; Zhao FH; Chen W; Zhang X; Kang LN; Paul P; Bai P; Peck R; Li J; Chen F; Stoler MH; Castle PE
Int J Cancer; 2016 Mar; 138(6):1453-61. PubMed ID: 26421807
[TBL] [Abstract][Full Text] [Related]
11. Reflex cytology for triage of high-risk human papillomavirus positive self-sampled material in cervical cancer screening: a prospective cohort study.
Loopik DL; Melchers W; Vedder J; van den Brule A; Massuger L; Bekkers R; Siebers AG
BJOG; 2020 Dec; 127(13):1656-1663. PubMed ID: 32506627
[TBL] [Abstract][Full Text] [Related]
12. Proof-of-principle study of a novel cervical screening and triage strategy: Computer-analyzed cytology to decide which HPV-positive women are likely to have ≥CIN2.
Schiffman M; Yu K; Zuna R; Terence Dunn S; Zhang H; Walker J; Gold M; Hyun N; Rydzak G; Katki HA; Wentzensen N
Int J Cancer; 2017 Feb; 140(3):718-725. PubMed ID: 27696414
[TBL] [Abstract][Full Text] [Related]
13. Screening for cervical cancer: new alternatives and research.
Lörincz AT
Salud Publica Mex; 2003; 45 Suppl 3():S376-87. PubMed ID: 14746031
[TBL] [Abstract][Full Text] [Related]
14. Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study.
Aitken CA; van Agt HME; Siebers AG; van Kemenade FJ; Niesters HGM; Melchers WJG; Vedder JEM; Schuurman R; van den Brule AJC; van der Linden HC; Hinrichs JWJ; Molijn A; Hoogduin KJ; van Hemel BM; de Kok IMCM
BMC Med; 2019 Dec; 17(1):228. PubMed ID: 31829241
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of human papilloma virus-DNA test verses colposcopy as secondary cervical cancer screening test to triage screen positive women on primary screening by visual inspection with 5% acetic acid.
Pimple S; Shastri SS
Indian J Cancer; 2014; 51(2):117-23. PubMed ID: 25104191
[TBL] [Abstract][Full Text] [Related]
16. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
17. Primary hrHPV DNA testing in cervical cancer screening: how to manage screen-positive women? A POBASCAM trial substudy.
Dijkstra MG; van Niekerk D; Rijkaart DC; van Kemenade FJ; Heideman DA; Snijders PJ; Meijer CJ; Berkhof J
Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):55-63. PubMed ID: 23733907
[TBL] [Abstract][Full Text] [Related]
18. Implementation of HPV-based cervical cancer screening in an organised regional screening programme: 3 years of experience.
Veijalainen O; Kares S; Kujala P; Vuento R; Osuala V; Tirkkonen M; Luukkaala T; Kholová I; Mäenpää J
Cytopathology; 2019 Mar; 30(2):150-156. PubMed ID: 30421573
[TBL] [Abstract][Full Text] [Related]
19. Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting.
Kotaniemi-Talonen L; Nieminen P; Anttila A; Hakama M
Br J Cancer; 2005 Oct; 93(8):862-7. PubMed ID: 16189520
[TBL] [Abstract][Full Text] [Related]
20. Sample Preparation Free Mass Spectrometry Using Laser-Assisted Rapid Evaporative Ionization Mass Spectrometry: Applications to Microbiology, Metabolic Biofluid Phenotyping, and Food Authenticity.
Cameron SJS; Perdones-Montero A; Van Meulebroek L; Burke A; Alexander-Hardiman K; Simon D; Schaffer R; Balog J; Karancsi T; Rickards T; Rebec M; Stead S; Vanhaecke L; Takáts Z
J Am Soc Mass Spectrom; 2021 Jun; 32(6):1393-1401. PubMed ID: 33980015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
